Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Scherman

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Radiation Oncology (London, England)|August 17, 2021
Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR imagesEmilia Persson, Sevgi Emin, Jonas Scherman, et al.
International Journal of Particle Therapy|December 3, 2019
Incorporating NTCP into Randomized Trials of Proton Versus Photon TherapyJonas Scherman, Ane L Appelt, Jen Yu, et al.
The British Journal of Radiology|September 24, 2019
Deep inspiration breath hold in locally advanced lung cancer radiotherapy: validation of intrafractional geometric uncertainties in the INHALE trialMirjana Josipovic, Marianne C Aznar, Jakob B Thomsen, et al.
Clinical and Translational Radiation Oncology|December 8, 2022
MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?Emilia Persson, Niklas Svanberg, Jonas Scherman, et al.
The British Journal of Radiology|July 6, 2018
Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancerSteen Riisgaard de Blanck, Jonas Scherman-Rydhög, Mette Siemsen, et al.
Radiation Oncology (London, England)|June 28, 2022
Pelvic U-Net: multi-label semantic segmentation of pelvic organs at risk for radiation therapy anal cancer patients using a deeply supervised shuffle attention convolutional neural networkMichael Lempart, Martin P Nilsson, Jonas Scherman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 2, 2017
Target position uncertainty during visually guided deep-inspiration breath-hold radiotherapy in locally advanced lung cancerJonas Scherman Rydhög, Steen Riisgaard de Blanck, Mirjana Josipovic, et al.
Acta Oncologica (Stockholm, Sweden)|March 24, 2020
Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose-response studiesLouise Stervik, Niclas Pettersson, Jonas Scherman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2016
Liquid fiducial marker performance during radiotherapy of locally advanced non small cell lung cancerJonas Scherman Rydhög, Steen Riisgaard Mortensen, Klaus Richter Larsen, et al.
Clinical and Translational Radiation Oncology|September 28, 2018
Long term safety and visibility of a novel liquid fiducial marker for use in image guided radiotherapy of non-small cell lung cancerSteen Riisgaard de Blanck, Jonas Scherman Rydhög, Klaus Richter Larsen, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Radiation Oncology (London, England)|August 17, 2021
Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR imagesEmilia Persson, Sevgi Emin, Jonas Scherman, et al.
International Journal of Particle Therapy|December 3, 2019
Incorporating NTCP into Randomized Trials of Proton Versus Photon TherapyJonas Scherman, Ane L Appelt, Jen Yu, et al.
The British Journal of Radiology|September 24, 2019
Deep inspiration breath hold in locally advanced lung cancer radiotherapy: validation of intrafractional geometric uncertainties in the INHALE trialMirjana Josipovic, Marianne C Aznar, Jakob B Thomsen, et al.
Clinical and Translational Radiation Oncology|December 8, 2022
MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?Emilia Persson, Niklas Svanberg, Jonas Scherman, et al.
The British Journal of Radiology|July 6, 2018
Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancerSteen Riisgaard de Blanck, Jonas Scherman-Rydhög, Mette Siemsen, et al.
Radiation Oncology (London, England)|June 28, 2022
Pelvic U-Net: multi-label semantic segmentation of pelvic organs at risk for radiation therapy anal cancer patients using a deeply supervised shuffle attention convolutional neural networkMichael Lempart, Martin P Nilsson, Jonas Scherman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 2, 2017
Target position uncertainty during visually guided deep-inspiration breath-hold radiotherapy in locally advanced lung cancerJonas Scherman Rydhög, Steen Riisgaard de Blanck, Mirjana Josipovic, et al.
Acta Oncologica (Stockholm, Sweden)|March 24, 2020
Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose-response studiesLouise Stervik, Niclas Pettersson, Jonas Scherman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2016
Liquid fiducial marker performance during radiotherapy of locally advanced non small cell lung cancerJonas Scherman Rydhög, Steen Riisgaard Mortensen, Klaus Richter Larsen, et al.
Clinical and Translational Radiation Oncology|September 28, 2018
Long term safety and visibility of a novel liquid fiducial marker for use in image guided radiotherapy of non-small cell lung cancerSteen Riisgaard de Blanck, Jonas Scherman Rydhög, Klaus Richter Larsen, et al.
Pageof 3